Abstract
Lisa Uchida, David R.W. Jayne
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
10.1056/nejmoa1803537
10.1056/nejmoa1803537
10.3899/jrheum.2025-0796
10.3899/jrheum.2025-0796
10.1146/annurev-pathol-011811-132453
10.1146/annurev-pathol-011811-132453
10.3949/ccjm.75.4.258
10.3949/ccjm.75.4.258
10.1053/ajkd.2002.29876
10.1053/ajkd.2002.29876
Diffuse alveolar hemorrhage secondary to antineutrophil cytoplasmic antibody-associated vasculitis: predictors of respiratory failure and clinical outcomes
10.1002/art.39562 · 2016
Plasma exchange for severe alveolar hemorrhage in antineutrophil cytoplasmic antibody-associated vasculitis: emulation of a target trial
2026
Alveolar hemorrhage in antineutrophil cytoplasmic antibody-associated vasculitis: results of an international randomized controlled trial (PEXIVAS)
10.1164/rccm.202308-1426oc · 2024
Immunoglobulin (Ig)M antibodies to proteinase 3 in granulomatosis with polyangiitis and microscopic polyangiitis
10.1111/cei.12925 · 2017
10.1053/j.ajkd.2022.10.017
10.1053/j.ajkd.2022.10.017
10.1136/bmj-2021-064604
10.1136/bmj-2021-064604
10.3109/03009742.2012.754939
10.3109/03009742.2012.754939
10.1001/jama.2018.16916
10.1001/jama.2018.16916
10.1002/0470092602
10.1002/0470092602
Avacopan for ANCA-associated vasculitis with hypoxic pulmonary haemorrhage
10.1093/ndt/gfae020 · 2024
Treatment of antineutrophil cytoplasmic antibody-associated vasculitis with diffuse alveolar hemorrhage with avacopan
10.1002/acr2.11726 · 2024
No additional external references are available.